eResearch Technology (ERT +16.9%) shares soar after Q4 results beat analyst estimates and Benchmark says it believes underlying clinical research industry trends recovered late in 2011 and have now returned to a favorable track. In raising shares to Buy, the firm expects improved margins, profitability and cash flow with the recent release of the Expert3 platform.
From other sites
at MarketWatch.com (Jun 21, 2012)
at MarketWatch.com (Apr 26, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs